A service that will provide physicians with objective and independent information on reimbursable drugs

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.343, 2001-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Open-Label Extension Studies: Do They Provide Meaningful Information on the Safety of New Drugs?

By Day Richard O. Williams Kenneth M.

Drug Safety, Vol. 30, Iss. 2, 2007-01 ,pp. : 93-105

Adis International

Access to resources Recommend Favorite

An increase in the number of reimbursable drugs has been called for by the National Institute of Old Age Pensioners

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 342, 2001-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Can Physicians Keep up? A Quantification of New Information on the Top 25 Drugs from 2000 to 2003

By Lobb William B. Kolassa E.M. (Mick)

Journal of Pharmaceutical Marketing & Management, Vol. 17, Iss. 1, 2006-08 ,pp. : 3-15

Haworth Press

Access to resources Recommend Favorite

Physicians still giving in to patient demands for branded drugs

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 670, 2013-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Access to Drugs, and Information

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 35, Iss. 4, 2005-12 ,pp. : 258-258

John Wiley & Sons Inc

Access to resources Recommend Favorite